This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Quality of Life  • Alzheimer Disease  • Behavioral Neurology  • Alert me on articles by topic

Hiroko H. Dodge, PhD; Changyu Shen, BS; Rajesh Pandav, MBBS, MPH; Steven T. DeKosky, MD; Mary Ganguli, MD, MPH

Arch Neurol. 2003;60:253-259.

Context  The concept of active life expectancy, the number of years a person can expect to live without disability, is used for the first time, to our knowledge, to examine the effect of Alzheimer disease (AD) on total life expectancy with different degrees of disability.

Objectives  To estimate and compare total life expectancy and average duration lived with different degrees of disability, between persons with and without AD.

Design  Ten-year prospective epidemiologic study.

Setting  A largely blue-collar rural community in Southwestern Pennsylvania.

Participants  A population-based cohort of 1201 subjects (at the beginning of follow-up) with a mean age of 75 years.

Main Outcome Measures  At age 70 and every 2 years thereafter, among persons with AD and nondemented persons, (1) the total expectancy of remaining life and (2) the duration lived with different numbers of impaired instrumental activities of daily living (IADLs), grouped as 0 to 1, 2 to 5, and 6 to 7 impairments.

Results  Alzheimer disease greatly shortened the total life expectancy to a similar extent in men and women, with the most pronounced reduction among those who were younger. Besides their shorter survival, men and women with AD spent more absolute years, and also a greater proportion of their remaining lives, with 6 to 7 IADL impairments than did their nondemented age peers. Nondemented women spent more years with 2 to 5 IADL impairments than nondemented men, while women with AD spent more years with 6 to 7 IADL impairments than men with AD.

Conclusion  The concept of active life expectancy adds a useful new dimension to the study of outcomes in AD.

From the Department of Epidemiology (Drs Dodge and Ganguli), the Department of Biostatistics, University of Pittsburgh Graduate School of Public Health (Mr Shen); the Division of Geriatrics and Neuropsychiatry, Department of Psychiatry (Drs Pandav, DeKosky, and Ganguli), and the Department of Neurology and Alzheimer's Research Center (Dr DeKosky), University of Pittsburgh School of Medicine, Pittsburgh, Pa.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
Dodge et al.
Neurology 2008;70:1809-1817.
ABSTRACT | FULL TEXT  

Associations of Gait Speed and Other Measures of Physical Function With Cognition in a Healthy Cohort of Elderly Persons
Fitzpatrick et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:1244-1251.
ABSTRACT | FULL TEXT  

The Burden of Diseases on Disability-Free Life Expectancy in Later Life
Jagger et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2007;62:408-414.
ABSTRACT | FULL TEXT  

Alzheimer Disease and Mortality: A 15-Year Epidemiological Study
Ganguli et al.
Arch Neurol 2005;62:779-784.
ABSTRACT | FULL TEXT  

Cognitive Impairment as a Strong Predictor of Incident Disability in Specific ADL-IADL Tasks Among Community-Dwelling Elders: The Azuchi Study
Dodge et al.
Gerontologist 2005;45:222-230.
ABSTRACT | FULL TEXT